» Articles » PMID: 27143583

Eradication Failure of Newly Acquired Pseudomonas Aeruginosa Isolates in Cystic Fibrosis

Abstract

Objectives: To determine eradication success rate of newly acquired PA and to identify characteristics associated with eradication failure.

Methods: In an observational study, data from patients with newly acquired PA infection from 2007 to 2013 were collected. Clinical variables were compared in patients with and without successful eradication for ≥1year.

Results: Of 183 patients out of 740 (25%) from 7 CF Centers that had newly acquired PA, eradication succeeded in 72%. Patients with the highest risk of failure had multi-resistant PA, fewer sputum cultures taken, were older, and were diagnosed at a later age. The risk of eradication failure increased by 1.3% with each year of delayed CF diagnosis; successful eradication increased by 17% with each additional sputum culture taken.

Conclusions: Delayed detection of PA infection leading to delayed treatment and growth of multi-resistant organisms is associated with eradication failure.

Citing Articles

Eradication treatment for infection in adults with bronchiectasis: a systematic review and meta-analysis.

Conceicao M, Shteinberg M, Goeminne P, Altenburg J, Chalmers J Eur Respir Rev. 2024; 33(171).

PMID: 38296344 PMC: 10828832. DOI: 10.1183/16000617.0178-2023.


Brazilian guidelines for the pharmacological treatment of the pulmonary symptoms of cystic fibrosis. Official document of the Sociedade Brasileira de Pneumologia e Tisiologia (SBPT, Brazilian Thoracic Association).

Athanazio R, Tanni S, Ferreira J, Dalcin P, Fuccio M, Esposito C J Bras Pneumol. 2023; 49(2):e20230040.

PMID: 37194817 PMC: 10171269. DOI: 10.36416/1806-3756/e20230040.


Calcium carbonate mineralization is essential for biofilm formation and lung colonization.

Cohen-Cymberknoh M, Kolodkin-Gal D, Keren-Paz A, Peretz S, Brumfeld V, Kapishnikov S iScience. 2022; 25(5):104234.

PMID: 35521519 PMC: 9062676. DOI: 10.1016/j.isci.2022.104234.


Changes in Care during the COVID-19 Pandemic for People with Cystic Fibrosis.

Sanders D, Wu R, ONeil T, Elbert A, Petren K, Jain R Ann Am Thorac Soc. 2022; 19(10):1697-1703.

PMID: 35143374 PMC: 9528741. DOI: 10.1513/AnnalsATS.202105-532OC.


Therapeutic Approach of Chronic Infection in Cystic Fibrosis-A Network Meta-Analysis.

Varannai O, Gede N, Juhasz M, Szakacs Z, Dembrovszky F, Nemeth D Antibiotics (Basel). 2021; 10(8).

PMID: 34438986 PMC: 8388982. DOI: 10.3390/antibiotics10080936.